BioCentury
ARTICLE | Company News

F2G, Dow antifungal deal

October 17, 2002 7:00 AM UTC

F2G (Manchester, U.K.) will screen libraries from Dow AgroSciences (Indianapolis, Ind.) for activity against human fungal pathogens. The companies will jointly synthesize resulting compounds. F2G will...